Das K C, Misra H P
Department of Biomedical Sciences, Virginia-Maryland Regional College of Veterinary Medicine, Blacksburg 24060-0442.
Mol Cell Biochem. 1992 Oct 7;115(2):179-85. doi: 10.1007/BF00230329.
Lidocaine, a local anaesthetic, has been shown to reduce ventricular arrhythmias associated with myocardial infarction and ischemic myocardial injury and its protective effects has been attributed to its membrane stabilizing properties. Since oxygen radicals are known to be produced during ischemia induced tissue damage, we have investigated the possible antioxidant properties of lidocaine and found that lidocaine does not scavenge O2-. radicals at 1 to 20 mM concentrations. However, lidocaine was found to be a potent scavenger of hydroxyl radicals and singlet oxygen. Hydroxyl radicals were produced in a Fenton type reaction and detected as DMPO-OH adducts by electron paramagnetic resonance spectroscopic techniques. Lidocaine inhibited DMPO-OH adduct formation in a dose dependent manner. The amount of lidocaine needed to cause 50% inhibition of that rate was found to be approximately 80 microM and at 300 microM concentration it virtually eliminated the DMPO-OH adduct formation. The production of OH.-dependent TBA reactive products of deoxyribose was also inhibited by lidocaine in a dose dependent manner. Lidocaine was also found to inhibit the 1O2-dependent 2,2,6,6-tetramethylpiperidine N-oxyl (TEMPO) formation in a dose dependent manner. 1O2 was produced in a photosensitizing system using Rose Bengal or Methylene Blue as photosensitizers and was detected as TEMP-1O2 adduct by EPR spectroscopy. The amount of lidocaine required to cause 50% inhibition of TEMP-1O2 adduct formation was found to be 500 microM. These results suggest that the protective effect of lidocaine on myocardial injury may, in part, be due to its reactive oxygen scavenging properties.(ABSTRACT TRUNCATED AT 250 WORDS)
利多卡因是一种局部麻醉剂,已被证明可减少与心肌梗死和缺血性心肌损伤相关的室性心律失常,其保护作用归因于其膜稳定特性。由于已知在缺血诱导的组织损伤过程中会产生氧自由基,我们研究了利多卡因可能的抗氧化特性,发现利多卡因在1至20 mM浓度下不会清除超氧阴离子自由基。然而,发现利多卡因是羟基自由基和单线态氧的有效清除剂。羟基自由基在芬顿型反应中产生,并通过电子顺磁共振光谱技术检测为DMPO-OH加合物。利多卡因以剂量依赖的方式抑制DMPO-OH加合物的形成。发现导致该速率50%抑制所需的利多卡因量约为80 microM,在300 microM浓度下,它实际上消除了DMPO-OH加合物的形成。利多卡因还以剂量依赖的方式抑制脱氧核糖的羟基自由基依赖性TBA反应性产物的产生。还发现利多卡因以剂量依赖的方式抑制单线态氧依赖性2,2,6,6-四甲基哌啶N-氧基(TEMPO)的形成。单线态氧在使用孟加拉玫瑰红或亚甲蓝作为光敏剂的光敏系统中产生,并通过电子顺磁共振光谱检测为TEMP-单线态氧加合物。发现导致TEMP-单线态氧加合物形成50%抑制所需的利多卡因量为500 microM。这些结果表明,利多卡因对心肌损伤的保护作用可能部分归因于其活性氧清除特性。(摘要截断于250字)